Proteasome Inhibitor News and Research

RSS
Study identifies risk factors for cardiotoxicity with relapsed multiple myeloma therapy

Study identifies risk factors for cardiotoxicity with relapsed multiple myeloma therapy

Intense exercise, fasting and hormones can enhance waste-protein removal, study shows

Intense exercise, fasting and hormones can enhance waste-protein removal, study shows

Researchers discover new therapeutic target for rare, aggressive pediatric cancers

Researchers discover new therapeutic target for rare, aggressive pediatric cancers

Leukogene receives STTR grant to optimize compound for treatment-resistant multiple myeloma

Leukogene receives STTR grant to optimize compound for treatment-resistant multiple myeloma

Janssen’s Darzalex receives positive CHMP opinion for treating multiple myeloma patients

Janssen’s Darzalex receives positive CHMP opinion for treating multiple myeloma patients

Researchers use x-ray crystallography to reveal how curcumin inhibits cancer

Researchers use x-ray crystallography to reveal how curcumin inhibits cancer

Scientists discover new treatment approach to curb severe myocarditis

Scientists discover new treatment approach to curb severe myocarditis

Proteasome inhibitor treatment can lead to cardiovascular problems in multiple myeloma patients

Proteasome inhibitor treatment can lead to cardiovascular problems in multiple myeloma patients

Insights from NGLY1 deficiency could provide new approach to treat blood cancers

Insights from NGLY1 deficiency could provide new approach to treat blood cancers

Scientists find new treatment option for rare autoimmune disease

Scientists find new treatment option for rare autoimmune disease

Whitehead Institute researchers identify mechanism underlying cancer drug-resistance

Whitehead Institute researchers identify mechanism underlying cancer drug-resistance

Study shows three-drug combination delays recurrence and lengthens life for myeloma patients

Study shows three-drug combination delays recurrence and lengthens life for myeloma patients

Carfilzomib therapy shows promise for pre-kidney transplant patients

Carfilzomib therapy shows promise for pre-kidney transplant patients

TJP1 protein could help determine multiple myeloma patients who may best benefit from proteasome inhibitors

TJP1 protein could help determine multiple myeloma patients who may best benefit from proteasome inhibitors

CHMP recommends conditional marketing authorisation for Janssen’s daratumumab

CHMP recommends conditional marketing authorisation for Janssen’s daratumumab

NIH-funded investigators develop therapeutic compound effective against malaria

NIH-funded investigators develop therapeutic compound effective against malaria

Amgen announces availability of Kyprolis (carfilzomib) in the UK for treatment of relapsed multiple myeloma

Amgen announces availability of Kyprolis (carfilzomib) in the UK for treatment of relapsed multiple myeloma

Takeda presents Phase 3 TOURMALINE-MM1 data for multiple myeloma at ASH 2015

Takeda presents Phase 3 TOURMALINE-MM1 data for multiple myeloma at ASH 2015

New approaches to treating leukemia, lymphoma and myeloma

New approaches to treating leukemia, lymphoma and myeloma

Takeda receives FDA approval for NINLARO (ixazomib) capsules to treat patients with multiple myeloma

Takeda receives FDA approval for NINLARO (ixazomib) capsules to treat patients with multiple myeloma